Zoe R Zeman
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biography and Research Information
OverviewAI-generated summary
Zoe R Zeman's research investigates strategies to reduce lameness in broiler chickens, a significant issue in poultry production. Their work focuses on the timing and duration of supplementing broiler diets with 1,25(OH)₂D₃ glycosides. This approach aims to mitigate bacterial chondronecrosis with osteomyelitis (BCO), a condition that leads to lameness and impacts animal welfare and economic outcomes in the poultry industry. Zeman has published findings on the effectiveness of specific inclusion timings for these glycosides, as well as studies examining the impact of different supplementation durations on BCO incidence.
Metrics
- Publications: 2
Selected Publications
-
Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers (2026)
-
Effect of 1,25(OH)₂D₃ Glycoside Supplementation Duration on Bacterial Chondronecrosis with Osteomyelitis (BCO) Lameness in Broilers (2026)Journal of the Arkansas Academy of Science OpenAlex
Collaboration Network
Top Collaborators
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
- Further Evaluation of 1,25(OH)2D3-Glycosides Inclusion Timing for Reducing Clinical Bacterial Chondronecrosis with Osteomyelitis-Induced Lameness Incidence in Broilers
Similar Researchers
Based on overlapping research topics